Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.640.790.981.081.73

What is the latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS is 0.64 based on Mar2024 Standalone results.
Year Fixed Capital/Sales
Mar20240.64
Mar20230.79
Mar20220.98
Mar20211.08
Mar20201.73

How is Fixed Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.64
-18.99
Mar2023 0.79
-19.39
Mar2022 0.98
-9.26
Mar2021 1.08
-37.57
Mar2020 1.73 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹182.3 Cr 7.3% 5.3% -23.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,400.0 Cr -0.3% 3.1% 13.4% Stock Analytics
DIVIS LABORATORIES ₹164,844.0 Cr 3.5% 11% 63.5% Stock Analytics
CIPLA ₹121,328.0 Cr 1.6% 2.7% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,521.0 Cr 4.1% 4.4% 24.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,043.0 Cr 6.8% 11.3% 3.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

7.3%

5.3%

-23.2%

SENSEX

2.7%

11.8%

14%


You may also like the below Video Courses